...
首页> 外文期刊>Journal of proteomics >Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance
【24h】

Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance

机译:卵巢癌细胞的比较2D-DIGE蛋白质组学分析:与获得性铂耐药相关的生物合成途径的重新定向

获取原文
获取原文并翻译 | 示例
           

摘要

Ovarian cancer is the fifth most frequent cause of cancer death in women. Emergence of chemoresistance in the course of treatments with platinum drugs is in part responsible for therapeutic failures. In order to improve the understanding of the complex mechanisms involved in acquired platinum chemoresistance, we decided to compare the basal protein expression profile of the platinum-sensitive cell line OAW42 and that of its resistant counterpart OAW42-R by a proteomic approach. Reversed-phase HPLC pre-fractionated extracts from both cell lines were subjected to 2D-DIGE coupled to mass spectrometry (MS). Forty eight differentially expressed proteins were identified, 39 being up-regulated and 19 down-regulated in OAW42-R versus OAW42 cells. From the current knowledge on biological activities of most differentially expressed proteins, it can be inferred that the acquisition of resistance was associated with a global reorganization of biochemical pathways favoring the production of precursors for biosynthesis, and with the mobilization of macromolecule quality control mechanisms, preserving RNA and protein integrity under damage-inducing conditions.
机译:卵巢癌是女性死于癌症的第五大常见原因。在用铂类药物治疗过程中出现化学抗药性是造成治疗失败的部分原因。为了更好地理解与获得性铂化学抗性有关的复杂机制,我们决定通过蛋白质组学方法比较铂敏感细胞系OAW42及其抗性对应物OAW42-R的基础蛋白表达谱。将来自两个细胞系的反相HPLC预分离提取物进行2D-DIGE偶联质谱分析(MS)。在OAW42-R与OAW42细胞中,鉴定出48种差异表达的蛋白质,其中39种被上调,而19种下调。根据目前对大多数差异表达蛋白的生物学活性的了解,可以推断出耐药性的获得与生物化学途径的全球重组有关,有利于生产用于生物合成的前体,并与动员大分子质量控制机制,保存在诱导损伤的条件下,RNA和蛋白质的完整性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号